您好,這是我第一個中文的blog message.
請問,入鍋您對Indianapolis 城市的biotech information 有影像,請您問我,我只會達ASAP.
謝謝
Tuesday, January 29, 2008
Monday, January 28, 2008
Biotechnology and Indianapolis
Central Indiana's connection to biotechnology begins with its early history; most notably Colonel Eli Lilly a pharmaceutical chemist who, after being frustrated with the poor quality of medicines available during his service in the American Civil War, opened his pharmaceutical research company in 1876 in Indianapolis. More can be found about the company he founded, Eli Lilly & Company, on the website www.lilly.com.
Indiana's central location made it just as much a crossroads in the past as it is today. As a result, medical technologies both efficacious and not made their way here. Devices that purported to have healing capabilities such as the dynamizer, a popular tool of the time, were franchised out to enterprising salespeople throughout the country. Technology designed to prey on the fears of the unknown surrounding your individual health and provide false hopes is nothing new. You can read about the dynamizer in a podcast transcript from Scientific American magazine http://www.sciam.com/podcast/episode.cfm?id=3B19B5E0-C66F-4457-646436E72B59234E.
As central Indiana enters a new era of biotechnological development, consideration should be given to how as citizens we can understand the differences between knowledge and hope, hype and results, and how we can grasp that there are consequences to not having a clear appreciation of how these worlds connect. A biotechnology company may be relying on both scientific facility and clever marketing to project itself into the marketplace; where does one end and the other begin? Should you wait until you need a treatment to consider how well a treatment works? These are questions that do not have easy answers, but I will attempt to address the issues at hand as I see them.
Indiana's central location made it just as much a crossroads in the past as it is today. As a result, medical technologies both efficacious and not made their way here. Devices that purported to have healing capabilities such as the dynamizer, a popular tool of the time, were franchised out to enterprising salespeople throughout the country. Technology designed to prey on the fears of the unknown surrounding your individual health and provide false hopes is nothing new. You can read about the dynamizer in a podcast transcript from Scientific American magazine http://www.sciam.com/podcast/episode.cfm?id=3B19B5E0-C66F-4457-646436E72B59234E.
As central Indiana enters a new era of biotechnological development, consideration should be given to how as citizens we can understand the differences between knowledge and hope, hype and results, and how we can grasp that there are consequences to not having a clear appreciation of how these worlds connect. A biotechnology company may be relying on both scientific facility and clever marketing to project itself into the marketplace; where does one end and the other begin? Should you wait until you need a treatment to consider how well a treatment works? These are questions that do not have easy answers, but I will attempt to address the issues at hand as I see them.
Subscribe to:
Comments (Atom)